Compare WMS & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMS | PTGX |
|---|---|---|
| Founded | 1966 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 8.5B |
| IPO Year | 2014 | 2016 |
| Metric | WMS | PTGX |
|---|---|---|
| Price | $141.91 | $136.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $180.63 | $108.23 |
| AVG Volume (30 Days) | 617.8K | ★ 691.9K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.44 | 0.05 |
| Revenue | ★ $3,050,376,000.00 | N/A |
| Revenue This Year | $5.23 | $874.25 |
| Revenue Next Year | $12.79 | N/A |
| P/E Ratio | ★ $25.82 | $2,708.60 |
| Revenue Growth | ★ 5.03 | N/A |
| 52 Week Low | $110.85 | $50.49 |
| 52 Week High | $179.32 | $143.29 |
| Indicator | WMS | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 44.22 | 59.49 |
| Support Level | $130.87 | $125.32 |
| Resistance Level | $144.56 | $141.10 |
| Average True Range (ATR) | 4.16 | 6.74 |
| MACD | -1.50 | -0.80 |
| Stochastic Oscillator | 16.16 | 58.87 |
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.